EUCAST News
Here you can find the latest news and updates from EUCAST.
Consultation on Breakpoints for C. diphtheriae and C. ulcerans.
The EUCAST general consultation on Corynebacterium diphtheriae and C. ulcerans is open for comments 9 July - 11 September, 2022. Together with specialists in Paris and Munich, 200 isolates of each species were investigated...[more]
Publication from the AFST 2022
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, Eric...[more]
Cefiderocol susceptibility testing
Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially available functioning test for cefiderocol MIC determination. EUCAST has investigated those available and all have problems with...[more]
Screening for azole and echinocandin resistance
Screening for azole and echinocandin resistanceexemplified in Aspergillus[more]
Warning against using material and devices for AST of species not listed as validated.
General warning against incomplete species and concentration range validation of commercially available susceptibility testing material and devices: In many cases manufacturers of susceptibility testing material and...[more]
Consultation (14 May - 15 June, extended to 15 July) on revised breakpoints for IV fosfomycin
EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin. Consultation period 14 May - 15 June, 2022. Revised breakpoints will be published in breakpoint table 2023.[more]
Consultation on the availability of piperacillin and ticarcillin without inhibitors.
EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin without clavulanic acid but only if these agents are no longer used. If you in your country are still using either or both of...[more]